<Record>
<Term>Nicotinic Antagonists</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Cholinergic Antagonists</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Physiological Effects of Drugs/Neurotransmitter Agents/Cholinergic Agents/Cholinergic Antagonists/Nicotinic Antagonists</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/Neurotransmitter Agents/Cholinergic Agents/Cholinergic Antagonists/Nicotinic Antagonists</ClassificationPath>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Cholinergic Antagonists</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Cholinergic Agents</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<BroaderTerm>Nicotinic Antagonists</BroaderTerm>
<BroaderTerm>Neurotransmitter Agents</BroaderTerm>
<BroaderTerm>Physiological Effects of Drugs</BroaderTerm>
<Synonym>Nicotinic Antagonists</Synonym>
<Description>Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.</Description>
<Source>MeSH</Source>
</Record>
